术后恶性高热——一种医疗急症：病例报告及文献综述
Postoperative Malignant Hyperthermia- A Medical Emergency: A Case Report and Review of Literature.
作者信息
Sinha Amit Kumar, Kumari Poonam, Vaghela Maheshkumar Manilal, Sinha Chandni, Kumar Bindey
机构信息
Senior Resident, Department of Pediatric Surgery, AIIMS, Patna, Bihar, India.
Senior Resident, Department of Anesthesiology, AIIMS, Patna, Bihar, India.
出版信息
J Clin Diagn Res. 2017 Apr;11(4):PD01-PD02. doi: 10.7860/JCDR/2017/20531.9493. Epub 2017 Apr 1.
Abstract
Malignant hyperthermia is a rare life threatening pharmacological disorder. Preoperative clinical diagnosis is not possible. Due to its rarity and severity, it must be taken as an important differential diagnosis for postoperative hyperthermia. We hereby report a case of postoperative malignant hyperthermia in a four-year-old female child, who was operated for type 1 choledochal cyst and had difficult postoperative sequel. We lost that child due to unavailability of Dantrolene sodium in emergency drug cart.
摘要
恶性高热是一种罕见的危及生命的药理学紊乱疾病。术前无法进行临床诊断。由于其罕见性和严重性，必须将其作为术后高热的重要鉴别诊断。我们在此报告一例四岁女童术后发生恶性高热的病例，该女童因1型胆总管囊肿接受手术，术后出现严重并发症。由于急救药车中没有丹曲林钠，我们失去了那个孩子。
相似文献
1
Postoperative Malignant Hyperthermia- A Medical Emergency: A Case Report and Review of Literature.
J Clin Diagn Res. 2017 Apr;11(4):PD01-PD02. doi: 10.7860/JCDR/2017/20531.9493. Epub 2017 Apr 1.
2
[Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Masui. 2014 Oct;63(10):1153-5.
3
Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.
Anesthesiology. 2018 Aug;129(2):249-259. doi: 10.1097/ALN.0000000000002231.
4
5
Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
J Clin Anesth. 1993 Jan-Feb;5(1):69-72. doi: 10.1016/0952-8180(93)90092-s.
6
Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Br J Anaesth. 2020 Aug;125(2):133-140. doi: 10.1016/j.bja.2020.04.089. Epub 2020 Jun 24.
7
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.
8
[Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
Rev Esp Anestesiol Reanim. 1992 Sep-Oct;39(5):309-11.
9
Successful management of malignant hyperpyrexia syndrome in a pediatric patient: What to do when dantrolene is not available?
J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):211-3. doi: 10.4103/0976-500X.171873.
10
A case of rapid progression of postoperative hyperthermia: Dantrolene or not dilemma?
Int J Crit Illn Inj Sci. 2016 Oct-Dec;6(4):203-205. doi: 10.4103/2229-5151.195451.
引用本文的文献
1
Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes.
J Gen Physiol. 2022 Nov 7;154(11). doi: 10.1085/jgp.202213136. Epub 2022 Oct 6.
2
A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke.
Nat Commun. 2021 Jul 13;12(1):4293. doi: 10.1038/s41467-021-24644-1.
3
The current status of malignant hyperthermia.
J Biomed Res. 2019 May 30;34(2):75-85. doi: 10.7555/JBR.33.20180089.
本文引用的文献
1
Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry.
Anesth Analg. 2014 Feb;118(2):369-374. doi: 10.1213/ANE.0b013e3182a8fad0.
2
Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
Anesthesiology. 2008 Nov;109(5):825-9. doi: 10.1097/ALN.0b013e31818958e5.
3
Benign hyperthermia following prolonged TIVA with propofol.
Can J Anaesth. 2000 Nov;47(11):1141-3. doi: 10.1007/BF03027969.
4
The effects of dantrolene on the contraction, relaxation, and energetics of the diaphragm muscle.
Anesth Analg. 1999 Aug;89(2):466-71. doi: 10.1097/00000539-199908000-00041.
5
Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
Anesth Analg. 1997 May;84(5):1038-41. doi: 10.1097/00000539-199705000-00016.
6
A clinical grading scale to predict malignant hyperthermia susceptibility.
Anesthesiology. 1994 Apr;80(4):771-9. doi: 10.1097/00000542-199404000-00008.
7
Markedly delayed postoperative malignant hyperthermia.
Arch Otolaryngol Head Neck Surg. 1986 May;112(5):564-6. doi: 10.1001/archotol.1986.03780050088017.
8
Combined anesthetic- and stress-induced malignant hyperthermia in two offspring of malignant hyperthermic-susceptible parents.
Anesth Analg. 1988 Apr;67(4):393-9.
9
Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2.
Can J Physiol Pharmacol. 1978 Jun;56(3):520-3. doi: 10.1139/y78-080.
10
Failure of lidocaine to trigger porcine malignant hyperthermia.
Anesth Analg. 1979 Mar-Apr;58(2):99-103. doi: 10.1213/00000539-197903000-00008.
Zotero 插件